Pairx

Pairx
Stealth ModeBiotechnology startup developing next-generation cancer immunotherapies targeting shared tumor-associated antigens.
About
What does Pairx do?
PairX Bio is a biotechnology startup focused on developing innovative cancer immunotherapies. Their platform leverages deep expertise in mRNA splicing biology and proprietary antigen validation methods to identify and target shared tumor-associated antigens derived from aberrantly spliced proteins. The company aims to create first- and best-in-class tumor-selective therapies for prevalent cancers.
What is Pairx's Effective Domain Rating?
StartupHub's Effective Domain Rating for Pairx is 78 out of 100, measuring real cross-surface visibility in search engines and AI answers rather than claimed link authority. That is underrated against its Ahrefs Domain Rating of 8, meaning it surfaces in search and AI results more than its claimed authority alone would suggest.
Is Pairx trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Pairx is 86 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
When was Pairx founded?
Pairx was founded in 2026.
What industry does Pairx operate in?
Pairx operates in Drug Discovery, Biotechnology, Cancer Immunotherapy, Oncology, Therapeutics, Biopharma.
Clinical Trial Discovery by ENSCORE.
Eccoscience is a startup focused on developing AI-powered solutions for scientific research and discovery.
AI-powered platform for clinical trial patient recruitment and data management.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
Ultimed develops an AI-powered platform to streamline medical imaging analysis and reporting for radiologists.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
Explore cutting-edge bio technology solutions with AI, launching soon.
AI-powered platform for tissue analysis and research.
An entrant is a company tagged Drug Discovery whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.